OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Blastic Plasmacytoid Dendritic Cell Neoplasm: From Origin of the Cell to Targeted Therapies
Kamel Laribi, Nathalie Denizon, Anne Besançon, et al.
Biology of Blood and Marrow Transplantation (2016) Vol. 22, Iss. 8, pp. 1357-1367
Open Access | Times Cited: 57

Showing 1-25 of 57 citing articles:

Dendritic cell subsets and locations
Sreekumar Balan, Mansi Saxena, Nina Bhardwaj
International review of cell and molecular biology (2019), pp. 1-68
Closed Access | Times Cited: 270

Treatment of blastic plasmacytoid dendritic cell neoplasm
Jill M. Sullivan, David A. Rizzieri
Hematology (2016) Vol. 2016, Iss. 1, pp. 16-23
Open Access | Times Cited: 92

Recurrent 8q24 rearrangement in blastic plasmacytoid dendritic cell neoplasm: association with immunoblastoid cytomorphology, MYC expression, and drug response
Kana Sakamoto, Ryohei Katayama, Reimi Asaka, et al.
Leukemia (2018) Vol. 32, Iss. 12, pp. 2590-2603
Closed Access | Times Cited: 73

Bone marrow clonal hematopoiesis is highly prevalent in blastic plasmacytoid dendritic cell neoplasm and frequently sharing a clonal origin in elderly patients
Mahsa Khanlari, C. Cameron Yin, Koichi Takahashi, et al.
Leukemia (2022) Vol. 36, Iss. 5, pp. 1343-1350
Closed Access | Times Cited: 37

North American Blastic Plasmacytoid Dendritic Cell Neoplasm Consortium: position on standards of care and areas of need
Naveen Pemmaraju, Hagop M. Kantarjian, Kendra Sweet, et al.
Blood (2022) Vol. 141, Iss. 6, pp. 567-578
Open Access | Times Cited: 30

Blastic plasmacytoid dendritic cell neoplasm: diagnosis, manifestations, and treatment
Kendra Sweet
Current Opinion in Hematology (2020) Vol. 27, Iss. 2, pp. 103-107
Closed Access | Times Cited: 37

Novel Therapeutic Approaches in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): Era of Targeted Therapy
Nathaniel R. Wilson, Marina Konopleva, Joseph D. Khoury, et al.
Clinical Lymphoma Myeloma & Leukemia (2021) Vol. 21, Iss. 11, pp. 734-740
Closed Access | Times Cited: 29

Dendritic cells in hematological malignancies
Domenico Galati, Gaetano Corazzelli, Rosaria De Filippi, et al.
Critical Reviews in Oncology/Hematology (2016) Vol. 108, pp. 86-96
Closed Access | Times Cited: 30

Novel treatment of blastic plasmacytoid dendritic cell neoplasm
Solomiya Grushchak, Cossette Joy, Arielle Gray, et al.
Medicine (2017) Vol. 96, Iss. 51, pp. e9452-e9452
Open Access | Times Cited: 30

An analysis of blastic plasmacytoid dendritic cell neoplasm with translocations involving the MYC locus identifies t(6;8)(p21;q24) as a recurrent cytogenetic abnormality
Lhara Sumarriva Lezama, Karen M. Chisholm, Eugene Carneal, et al.
Histopathology (2018) Vol. 73, Iss. 5, pp. 767-776
Closed Access | Times Cited: 27

Blastic Plasmacytoid Dendritic Cell Neoplasm
Éric Deconinck, Tony Petrella, Francine Garnache Ottou
Hematology/Oncology Clinics of North America (2020) Vol. 34, Iss. 3, pp. 491-500
Open Access | Times Cited: 21

Immunotherapies Targeting CD123 for Blastic Plasmacytoid Dendritic Cell Neoplasm
Tongyuan Xue, Lihua E. Budde
Hematology/Oncology Clinics of North America (2020) Vol. 34, Iss. 3, pp. 575-587
Closed Access | Times Cited: 21

Pediatric blastic plasmacytoid dendritic cell neoplasm: report of four cases and review of literature
Chan Liao, Nan-Xia Hu, Hua Song, et al.
International Journal of Hematology (2021) Vol. 113, Iss. 5, pp. 751-759
Closed Access | Times Cited: 16

Blastic Plasmacytoid Dendritic Cell Neoplasm, from a Dermatological Point of View
Cosimo Di Raimondo, Flavia Lozzi, Pier Paolo Di Domenico, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 7099-7099
Open Access | Times Cited: 2

Emerging trends in immunotoxin targeting cancer stem cells
Belay Zeleke Sibuh, Rekha Gahtori, Noura Al‐Dayan, et al.
Toxicology in Vitro (2022) Vol. 83, pp. 105417-105417
Closed Access | Times Cited: 10

Blastic plasmacytoid dendritic cell neoplasm: challenges and future prospects
Amy M. Trottier, Sonia Cerquozzi, Carolyn Owen
Blood and Lymphatic Cancer Targets and Therapy (2017) Vol. Volume 7, pp. 85-93
Open Access | Times Cited: 17

Social Media and Internet Resources for Patients with Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
Naveen Pemmaraju, Vikas Gupta, Michael A. Thompson, et al.
Current Hematologic Malignancy Reports (2016) Vol. 11, Iss. 6, pp. 462-467
Closed Access | Times Cited: 16

Global assessment of IRF8 as a novel cancer biomarker
Daniel McQuaid, Gauri Panse, Wei‐Lien Wang, et al.
Human Pathology (2022) Vol. 122, pp. 1-10
Open Access | Times Cited: 9

Tagraxofusp as treatment for patients with blastic plasmacytoid dendritic cell neoplasm
Sophia S. Lee, Deborah McCue, Naveen Pemmaraju
Expert Review of Anticancer Therapy (2020) Vol. 20, Iss. 7, pp. 543-550
Closed Access | Times Cited: 12

Ulcerating skin lesions from blastic plasmacytoid dendritic cell neoplasm responding to low-dose radiotherapy—a case report and literature review
Elgin Hoffmann, Simon Böke, Chiara De‐Colle, et al.
Strahlentherapie und Onkologie (2024)
Open Access | Times Cited: 1

Improved identification of clinically relevant Acute Leukemia subtypes using standardized EuroFlow panels versus non‐standardized approach
Rafik Terra, Vincent Éthier, Lambert Busque, et al.
Cytometry Part B Clinical Cytometry (2024)
Open Access | Times Cited: 1

Dendritic Cell Leukemia: a Review
Nikolaos J. Tsagarakis, Georgios Paterakis
Current Oncology Reports (2020) Vol. 22, Iss. 6
Closed Access | Times Cited: 11

Blastic Plasmacytoid Dendritic Cell Neoplasm: Single Center Experience on a Rare Hematological Malignancy
Zehra Narlı Özdemir, Güldane Cengiz Seval, Uğur Şahin, et al.
Indian Journal of Hematology and Blood Transfusion (2020) Vol. 37, Iss. 1, pp. 67-75
Open Access | Times Cited: 9

Mature plasmacytoid dendritic cells associated with acute myeloid leukemia show similar genetic mutations and expression profiles to leukemia cells
Xiaoyuan Gong, Chunhong Li, Ying Wang, et al.
Blood Science (2022) Vol. 4, Iss. 1, pp. 38-43
Open Access | Times Cited: 6

Blastic Plasmocytoid Dendritic Cell Neoplasm (BPDCN): Clinical Features and Histopathology with a Therapeutic Overview
Gerardo Cazzato, Marialessandra Capuzzolo, Emilio Bellitti, et al.
Hematology Reports (2023) Vol. 15, Iss. 4, pp. 696-706
Open Access | Times Cited: 3

Page 1 - Next Page

Scroll to top